Michael P. Veve, PharmD
Assistant Professor
![]() 1924 ALCOA HIGHWAY KNOXVILLE TN 37920 ![]() ![]() |
Education
- M.P.H., Wayne State University College of Medicine, Detroit MI
- Infectious Diseases Pharmacotherapy Fellowship, Wayne State University/Henry Ford Hospital, Detroit MI
- PGY-1 Pharmacy Practice Residency, Henry Ford Hospital, Detroit MI
- Pharm.D., Albany College of Pharmacy, Albany NY
Research Interest/Specialty
i. Epidemiology of bacterial and fungal infections
ii. Clinical and economic implications of antimicrobial resistance
iii. Optimization of antimicrobial exposures in select populations
iv. Health-care access in underserved populations
Clinical Care Specialty/Interest
Antimicrobial stewardship, management of multi-drug resistant organisms, invasive fungal infections, Clostridioides difficile-associated diarrhea, antimicrobial optimization in critically ill and/or immunocompromised populations, infections related to injection-drug use
Publications
- Veve, MP, Greene, JB, Williams, AM, Davis, SL, Lu, N, Shnayder, Y, Li, DX, Noureldine, SI, Richmon, JD, Lin, LO, Hanasono, MM, Pipkorn, P, Jackson, RS, Hornig, JD, Light, T, Wax, MK, Yiu, Y, Bekeny, J, Old, M, Hernandez, D, Patel, UA, Ghanem, TA. Multicenter Assessment of Antibiotic Prophylaxis Spectrum on Surgical Infections in Head and Neck Cancer Microvascular Reconstruction. Otolaryngol Head Neck Surg, 194599818756299, 2018.
- Athans, V, Veve, MP, Davis, SL. Trowels and Tribulations: Review of Antimicrobial-Impregnated Bone Cements in Prosthetic Joint Surgery. Pharmacotherapy, 37 (12), 1565-1577, 2017.
- Veve, MP, Davis, SL, Williams, AM, McKinnon, JE, Ghanem, TA. Considerations for antibiotic prophylaxis in head and neck cancer surgery. Oral Oncol, 74, 181-187, 2017.
- Flynt, LK, Veve, MP, Samuel, LP, Tibbetts, RJ. Comparison of Etest to Broth Microdilution for Testing of Susceptibility of Pseudomonas aeruginosa to Ceftolozane-Tazobactam. J Clin Microbiol, 55 (1), 334-335, 2017.
- Veve, MP, Wagner, JL, Kenney, RM, Grunwald, JL, Davis, SL. Comparison of fosfomycin to ertapenem for outpatient or step-down therapy of extended-spectrum β-lactamase urinary tract infections. Int J Antimicrob Agents, 48 (1), 56-60, 2016.
- Patel, N, Veve, M, Nasiri, M, Bliss, S, McNutt, LA, Lazariu, V, Miller, C. Predicting the probability of experiencing clinically significant drug-drug interactions involving boceprevir-containing hepatitis C therapy among patients coinfected with hepatitis C and HIV. AIDS Patient Care STDS, 28 (10), 513-6, 2014.
- Patel N, Veve MP, Bliss S, Nasiri M, McNutt LA, Lazariu V, Roman M, Miller CD. Prevalence and predictors of important telaprevir drug interactions among patients co-infected with hepatitis C and human immunodeficiency virus.. J Pharm Technol, 5 (30), 159-67, 2014.
- Patel, N, Veve, M, Kwon, S, McNutt, LA, Fish, D, Miller, CD. Frequency of electrocardiogram testing among HIV-infected patients at risk for medication-induced QTc prolongation. HIV Med, 14 (8), 463-71, 2013.
- Patel, N, Abdelsayed, S, Veve, M, Miller, CD. Predictors of clinically significant drug-drug interactions among patients treated with nonnucleoside reverse transcriptase inhibitor-, protease inhibitor-, and raltegravir-based antiretroviral regimens. Ann Pharmacother, 45 (3), 317-24, 2011.